Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 

SCSHP Annual Meeting 2021 (Virtual Conference)


SCSHP 2021 Annual Meeting
Wednesday, March 3 - Friday March 5, 2021
 
To register and view the full meeting agenda, visit https://scshp.com/meetinginfo.php?id=6&ts=1611759464
 
Location:  Online Virtual Platform 
 
For all continuing education session details, including speakers and learning objectives, please expand the individual sessions below! 
 

Date: Mar 3, 2021 03:30 PM - Mar 5, 2021 03:30 PM

CE Hours

10.50

CE Units

1.050

Activity Type

  • Knowledge-Based and Application-Based

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

SCSHP

Requirements for CE Credit

In order to claim credit and have CE credit submitted to the CPE Monitor, participants must complete the following steps within 60 days of the event.  Completion of these steps within 30 days of the event will allow for any issues in transmission to NABP to be rectified by our office. The CPE Monitor will not accept credit that is submitted greater than 60 days after the event per NABP policy.
  1. Check in upon arrival at the meeting
  2. Complete and submit the "CE Sign In" form at the meeting
  3. Complete the online program evaluations
  4. Provide the correct month and day of birth and NABP e-Profile ID.  Registration with a proper disclosure of your NABP E-Profile ID is a requirement for receiving Continuing Pharmacy Education.  To register with or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site.  

 

 

 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
  2. Summarize clinical knowledge in response to a case vignette using supporting laboratory, physical examination, and medical history information
  3. Discuss numerous drug therapy and specialty areas through response to pharmacotherapy questions

Speaker(s)/Author(s)

Jason S. Haney, PharmD, BCPS, BCCCP
Associate Professor, Medical University of South Carolina College of Pharmacy; Clinical Pharmacy Specialist, MUSC Health Pharmacotherapy Clinics

Whitney Maxwell, PharmD, MBA, BCPS
Associate Director of Experiential Education and Clinical Associate Professor, University of South Carolina College of Pharmacy

Activity Number

0062-9999-21-014-L01-P/T
Date: 03/03/21
Time: 03:30 PM - 04:30 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Discuss emerging research outcomes from throughout the state of South Carolina
  2. Recognize novel ideas for research and quality initiative projects in your pharmacy practice areas
  3. Review pivotal results from local investigations across the state of South Carolina

Speaker(s)/Author(s)

Abigail Will, PharmD
PGY2 Pharmacy Resident, Community-Based Pharmacy Administration & Leadership, University of South Carolina College of Pharmacy/Premise Health

Sarah Bruner
2021 PharmD Candidate, Medical University of South Carolina College of Pharmacy

Zachariah Gunter, PharmD
PGY2 Health-System Pharmacy Administration and Leadership Resident, Medical University of South Carolina

Activity Number

0062-9999-21-015-L04-P/T
Date: 03/03/21
Time: 04:30 PM - 05:30 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
  2. Summarize clinical knowledge in response to a case vignette using supporting laboratory, physical examination, and medical history information
  3. Discuss numerous drug therapy and specialty areas through response to pharmacotherapy questions

Speaker(s)/Author(s)

Jason S. Haney, PharmD, BCPS, BCCCP
Associate Professor, Medical University of South Carolina College of Pharmacy; Clinical Pharmacy Specialist, MUSC Health Pharmacotherapy Clinics

Whitney Maxwell, PharmD, MBA, BCPS
Associate Director of Experiential Education and Clinical Associate Professor, University of South Carolina College of Pharmacy

Activity Number

0062-9999-21-016-L01-P/T
Date: 03/03/21
Time: 05:30 PM - 06:00 PM

CE Hours

0.50
 

 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Describe the prevalence of and implications associated with pharmacist and pharmacy technician burnout
  2. Identify risk factors and symptoms of burnout in ourselves and other healthcare team members
  3. Discuss resources and strategies to help manage burnout, with a focus on the COVID-19 pandemic
  4. Develop a plan that can be implemented by pharmacists and pharmacy technicians to help minimize burnout and increase resiliency

Speaker(s)/Author(s)

Amy Hebbard, PharmD, BCPP
Psychiatry Pharmacy Coordinator, Medical University of South Carolina

Sarah Harrison, PharmD, BCCCP
Clinical Pharmacy Coordinator, Medical University of South Carolina

Activity Number

0062-9999-21-017-L04-P/T
Date: 03/04/21
Time: 10:00 AM - 11:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Discuss existing pharmacotherapy recommendations for the management of emergent status epilepticus
  2. Describe current clinical practice in the pre-hospital and hospital settings
  3. Interpret current evidence and its potential impact on clinical practice variations
  4. Identify opportunities to ensure optimal dosing and timing of antiepileptic medications in the pre-hospital and hospital setting based on current recommendations
  5. Hypothesize areas for future exploration in the pharmacotherapy management of emergent status epilepticus
 
At the completion of this activity, the pharmacy technician will be able to:
  1. Identify emergently needed pharmacotherapy agents for the management of status epilepticus
  2. Interpret the importance of time in the implementation of pharmacotherapy in the management of status epilepticus

Speaker(s)/Author(s)

Kyle Weant, PharmD, BCPS, BCCCP, FCCP
Clinical Assistant Professor and Emergency Medicine Clinical Pharmacy Specialist, University of South Carolina College of Pharmacy

Activity Number

0062-9999-21-018-L01-P/T
Date: 03/04/21
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Explain current state and federal requirements for reporting diversion concern and loss of controlled substances
  2. Discuss with their institution the key components required for a multi-disciplinary Drug Diversion Committee and Diversion Response Team
  3. Review different patient care area types and identify areas of vulnerability
 
At the completion of this activity, the pharmacy technician will be able to:
  1. Recognize and report possible concerns relating to controlled substance security within the pharmacy and on nursing units
  2. Investigate and appropriately respond to issues encountered at the Automated Dispensing Cabinets

Speaker(s)/Author(s)

Bethanie Gamble, PharmD
Diversion and Compliance Pharmacist, Prisma Health Upstate

Activity Number

0062-9999-21-019-L03-P/T
Date: 03/04/21
Time: 01:15 PM - 02:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Review common goals and barriers faced by early-career practitioners
  2. Illustrate the importance of early-career mentorship as a foundation for prolonged personal and professional growth
  3. Identify opportunities for seasoned practitioners to expand their mentorship skills and support network
  4. Summarize experiences of a panel of diverse early-career practitioners and seasoned mentors as real-world examples of the impact of early-career mentorship

Speaker(s)/Author(s)

Brandon Hill, PharmD, BCIDP, BCPS
Clinical Pharmacist - Infectious Diseases, UVA Health

Krutika N. Mediwala, PharmD, BCPS, BCIDP
Clinical Pharmacy Specialist – Infectious Diseases/Antimicrobial Stewardship; Residency Program Director, PGY2 Infectious Diseases Residency, MUSC Health

Activity Number

0062-9999-21-020-L04-P/T
Date: 03/04/21
Time: 02:30 PM - 03:30 PM

CE Hours

1.00
 

 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Describe pharmacist requirements in the South Carolina Overdose Prevention Act for the dispensing of naloxone without a prescription or standing order
  2. Identify ways for pharmacists and technicians to reduce stigma and communication barriers when providing opioid overdose education, including the proper use of naloxone.
  3. Demonstrate the value of utilizing academic detailing principles in student-led interventions to engage pharmacists in practice behavior changes that aid in the expansion of access to naloxone

Speaker(s)/Author(s)

Elizabeth Weed, PharmD
Director of Experiential Education, Medical University of South Carolina and Palmetto Experiential Education Partnership

Megan Pruitt, PharmD
SCORxE Clinical Pharmacy Consultant, MUSC College of Pharmacy

Talisha Ratliff, PharmD
Executive Director of Experiential Education, Presbyterian College School of Pharmacy

Activity Number

0062-9999-21-021-L08-P/T
Date: 03/05/21
Time: 10:00 AM - 11:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Define asymptomatic bacteriuria (ASB) and urinary tract infection (UTI)
  2. Differentiate between ASB and UTI in a complicated clinical case
  3. Design an appropriate treatment regimen for patients with complicated UTIs, including agent selection, dose, and duration
At the completion of this activity, the pharmacy technician will be able to:
  1. Define asymptomatic bacteriuria (ASB) and urinary tract infection (UTI)
  2. Recall differences in management of ASB and UTIs
  3. Identify pharmacotherapy agents used in the treatment of complicated UTIs

Speaker(s)/Author(s)

Rachel Britt, PharmD, BCIDP
Clinical Practice Specialist–Infectious Diseases, UTMB Health

Activity Number

0062-9999-21-022-L01-P/T
Date: 03/05/21
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Describe how to identify and manage a drug shortage
  2. Demonstrate how pharmacy staff are uniquely positioned to identify and solve drug supply shortages
  3. Recognize how pharmacists must communicate effectively with other healthcare professionals to efficiently manage shortages
At the completion of this activity, the pharmacy technician will be able to:
  1. Demonstrate how use of pharmacy information systems aid in the identification and management of drug shortages
  2. Describe the pharmacy technician role in maintaining accurate stock of pharmaceutical inventory
  3. Recognize the pharmacy technician role in mitigating shortages using multiple strategies

Speaker(s)/Author(s)

Amy Schaefer, PharmD
Supply Chain Information System Pharmacist, Prisma Health - Upstate

Chloé LeBegue, PharmD
Pharmacist in Charge – Compounding and Repackaging, Prisma Health - Upstate

Activity Number

062-9999-21-023-L04-P/T
Date: 03/05/21
Time: 01:15 PM - 02:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Summarize treatment recommendations from the American Diabetes Association and American College of Clinical Endocrinology for type 2 diabetes (T2D)
  2. Given a patient case, assess the benefits and risks of glucagon-like peptide-1 receptor agonists, as a first-line option, for a person with T2D
  3. Given a patient case, assess the benefits and risks of sodium glucose co-transporter-2 inhibitors, as a first-line option, for a person with T2D
At the completion of this activity, the pharmacy technician will be able to:
  1. Describe the role of glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose co-transporter-2 inhibitors (SGLT2i) for type 2 diabetes (T2D)
  2. Identify a benefit and risk of GLP-1 RA, as a first-line option, for a person with T2D
  3. Identify a benefit and risk of SGLT2i, as a first-line option, for a person with T2D

Speaker(s)/Author(s)

Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
Clinical Pharmacist - Diabetes Transition, Spartanburg Regional Healthcare System

Sarah Anderson, PharmD, FCCP, FASHP, BCPS, BCACP
Associate Professor and Clinical Pharmacy Specialist, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and Denver Health Eastside Clinic

Activity Number

0062-9999-21-024-L01-P/T
Date: 03/05/21
Time: 02:30 PM - 03:30 PM

CE Hours

1.00